Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Jun 30, 2025 | (FY)Jun 30, 2024 | (FY)Jun 30, 2023 | (FY)Jun 30, 2022 | (FY)Jun 30, 2021 | (FY)Jun 30, 2020 | |
|---|---|---|---|---|---|---|
| Operating cash flow (direct method) | ||||||
| Cash income from operating activities | 61.40%178.25M | 1.61%110.44M | -15.01%108.7M | -0.10%127.89M | 23.79%128.02M | 103.42M |
| Revenue from customers | 61.40%178.25M | 1.61%110.44M | -15.01%108.7M | -0.10%127.89M | 23.79%128.03M | --103.42M |
| Other cash income from operating activities | ---- | ---- | ---- | ---- | ---1K | ---- |
| Cash paid | -61.85%-166.32M | 3.88%-102.76M | 18.90%-106.91M | -9.79%-131.82M | -23.21%-120.06M | -97.44M |
| Payments to suppliers for goods and services | -61.85%-166.32M | 3.88%-102.76M | 18.90%-106.91M | -9.79%-131.82M | -23.21%-120.06M | ---97.44M |
| Direct interest paid | -10.02%-2.09M | 3.61%-1.9M | -37.94%-1.97M | 0.70%-1.43M | 10.47%-1.44M | ---1.6M |
| Direct interest received | 231.11%149K | 462.50%45K | -27.27%8K | 10.00%11K | -47.37%10K | --19K |
| Direct tax refund paid | -192.74%-332K | 62.73%358K | --220K | ---- | 184.52%475K | ---562K |
| Operating cash flow | 56.12%9.66M | 13,059.57%6.19M | 100.88%47K | -176.14%-5.34M | 83.20%7.01M | --3.83M |
| Investing cash flow | ||||||
| Cash flow from continuing investing activities | 58.57%-1.14M | -209.09%-2.76M | 329.88%2.53M | -94.87%-1.1M | 81.20%-565K | -3.01M |
| Net PPE purchase and sale | 43.66%-1.1M | -2,898.46%-1.95M | 79.37%-65K | 49.60%-315K | 81.44%-625K | ---3.37M |
| Net business purchase and sale | ---- | ---50K | ---- | ---46K | ---- | ---- |
| Net investment purchase and sale | 94.33%-46K | -131.28%-812K | 450.81%2.6M | -1,296.23%-740K | -114.68%-53K | --361K |
| Cash from discontinued investing activities | ||||||
| Investing cash flow | 58.57%-1.14M | -209.09%-2.76M | 329.88%2.53M | -94.87%-1.1M | 81.20%-565K | ---3.01M |
| Financing cash flow | ||||||
| Cash flow from continuing financing activities | 43.58%-2.4M | -801.27%-4.25M | -113.69%-471K | 167.54%3.44M | -262.98%-5.09M | 3.13M |
| Net issuance payments of debt | 246.47%1.62M | -158.61%-1.11M | -52.73%1.89M | 1,383.60%3.99M | -127.19%-311K | --1.14M |
| Net common stock issuance | ---- | ---- | ---- | --3.8M | ---- | --4.54M |
| Cash dividends paid | -100.60%-670K | ---334K | ---- | ---- | ---- | ---- |
| Net other financing activities | -19.25%-3.35M | 40.52%-2.81M | 49.46%-4.72M | 0.65%-9.33M | -83.51%-9.39M | ---5.12M |
| Cash from discontinued financing activities | ||||||
| Financing cash flow | 43.58%-2.4M | -801.27%-4.25M | -113.69%-471K | 167.54%3.44M | -262.98%-5.09M | --3.13M |
| Net cash flow | ||||||
| Beginning cash position | -8.66%8.29M | 30.85%9.07M | -30.21%6.93M | 15.42%9.93M | 85.98%8.61M | --4.63M |
| Current changes in cash | 845.07%6.12M | -138.97%-821K | 170.21%2.11M | -321.48%-3M | -65.67%1.36M | --3.95M |
| Effect of exchange rate changes | 80.00%63K | 9.38%35K | 128.57%32K | 150.00%14K | -187.50%-28K | --32K |
| End cash Position | 74.58%14.47M | -8.66%8.29M | 30.85%9.07M | -30.21%6.93M | 15.42%9.93M | --8.61M |
| Free cash from | 108.23%8.22M | 764.81%3.95M | 89.50%-594K | -188.53%-5.66M | 1,417.34%6.39M | --421K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |